OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Overview of stem cells therapy in amyotrophic lateral sclerosis
Goun Je, Kiandokht Keyhanian, Mehdi Ghasemi
Neurological Research (2021) Vol. 43, Iss. 8, pp. 616-632
Closed Access | Times Cited: 14
Goun Je, Kiandokht Keyhanian, Mehdi Ghasemi
Neurological Research (2021) Vol. 43, Iss. 8, pp. 616-632
Closed Access | Times Cited: 14
Showing 14 citing articles:
Stem cell therapies for neurological disorders: current progress, challenges, and future perspectives
Ramyar Rahimi Darehbagh, Seyedeh Asrin Seyedoshohadaei, Rojin Ramezani, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 20
Ramyar Rahimi Darehbagh, Seyedeh Asrin Seyedoshohadaei, Rojin Ramezani, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 20
Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis
Kim A. Staats, David Borchelt, Malú G. Tansey, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 51
Kim A. Staats, David Borchelt, Malú G. Tansey, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 51
Comprehensive Research on Past and Future Therapeutic Strategies Devoted to Treatment of Amyotrophic Lateral Sclerosis
Belgin Sever, Halil I. Ciftci, Hasan DeMi̇rci̇, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2400-2400
Open Access | Times Cited: 50
Belgin Sever, Halil I. Ciftci, Hasan DeMi̇rci̇, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2400-2400
Open Access | Times Cited: 50
The Use of Stem Cells as a Potential Treatment Method for Selected Neurodegenerative Diseases: Review
Elżbieta Cecerska‐Heryć, Maja Pękała, Natalia Serwin, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 6, pp. 2643-2673
Open Access | Times Cited: 35
Elżbieta Cecerska‐Heryć, Maja Pękała, Natalia Serwin, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 6, pp. 2643-2673
Open Access | Times Cited: 35
Therapeutic targeting ofALS pathways: Refocusing an incomplete picture
Nicholas J. Maragakis, Mamede de Carvalho, Michael D. Weiss
Annals of Clinical and Translational Neurology (2023) Vol. 10, Iss. 11, pp. 1948-1971
Open Access | Times Cited: 15
Nicholas J. Maragakis, Mamede de Carvalho, Michael D. Weiss
Annals of Clinical and Translational Neurology (2023) Vol. 10, Iss. 11, pp. 1948-1971
Open Access | Times Cited: 15
Neural Stem/Progenitor Cell Therapy in Patients and Animals with Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-analysis
Ji Zhang, Ruiyun Guo, Zijing Zhou, et al.
Molecular Neurobiology (2025)
Closed Access
Ji Zhang, Ruiyun Guo, Zijing Zhou, et al.
Molecular Neurobiology (2025)
Closed Access
Current insights in the molecular genetic pathogenesis of amyotrophic lateral sclerosis
Zhou Wan, Renshi Xu
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 11
Zhou Wan, Renshi Xu
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 11
Current Therapy in Amyotrophic lateral sclerosis (ALS): a review on Past and Future Therapeutic Strategies
Yuqing Wei, Sheng Zhong, Huajing Yang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116496-116496
Closed Access | Times Cited: 1
Yuqing Wei, Sheng Zhong, Huajing Yang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116496-116496
Closed Access | Times Cited: 1
Current potential diagnostic biomarkers of amyotrophic lateral sclerosis
Zheqi Xu, Renshi Xu
Reviews in the Neurosciences (2024) Vol. 35, Iss. 8, pp. 917-931
Closed Access | Times Cited: 1
Zheqi Xu, Renshi Xu
Reviews in the Neurosciences (2024) Vol. 35, Iss. 8, pp. 917-931
Closed Access | Times Cited: 1
Umbilical cord mesenchymal stem cell-conditioned medium inhibits microglial activation to ameliorate neuroinflammation in amyotrophic lateral sclerosis mice and cell models
Jingshu Tang, Yuying Kang, Yujun Zhou, et al.
Brain Research Bulletin (2023) Vol. 202, pp. 110760-110760
Open Access | Times Cited: 3
Jingshu Tang, Yuying Kang, Yujun Zhou, et al.
Brain Research Bulletin (2023) Vol. 202, pp. 110760-110760
Open Access | Times Cited: 3
La sclérose latérale amyotrophique : une maladie neurodégénérative emblématique
Fausto Viader
Bulletin de l Académie Nationale de Médecine (2023) Vol. 207, Iss. 3, pp. 272-286
Open Access | Times Cited: 2
Fausto Viader
Bulletin de l Académie Nationale de Médecine (2023) Vol. 207, Iss. 3, pp. 272-286
Open Access | Times Cited: 2
Neural Stem Cell Therapies: Promising Treatments for Neurodegenerative Diseases
Amir Gholamzad, Hadis Sadeghi, Maryam Azizabadi Farahani, et al.
Neurology Letters (2023) Vol. 2, Iss. 2, pp. 55-68
Open Access | Times Cited: 2
Amir Gholamzad, Hadis Sadeghi, Maryam Azizabadi Farahani, et al.
Neurology Letters (2023) Vol. 2, Iss. 2, pp. 55-68
Open Access | Times Cited: 2
Immunosuppression in stem cell clinical trials of neural and retinal cell types: A systematic review
Shravan Gowrishankar, Matthew E. Smith, Nathan J. Creber, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0304073-e0304073
Open Access
Shravan Gowrishankar, Matthew E. Smith, Nathan J. Creber, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0304073-e0304073
Open Access
Emerging Therapeutics and Delivery
Alekha K. Dash, Babu M. Medi, Behnaz Sarrami, et al.
Pharmaceutics (2023), pp. 437-469
Open Access
Alekha K. Dash, Babu M. Medi, Behnaz Sarrami, et al.
Pharmaceutics (2023), pp. 437-469
Open Access
